Amicus Therapeutics Inc (NASDAQ: FOLD) May Be Attracting Institutional Investments

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

Amicus Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Amicus Therapeutics Inc is $3.05B. A total of 1.17 million shares were traded on the day, compared to an average of 2.51M shares.

In the most recent transaction, Campbell Bradley L sold 6,100 shares of FOLD for 10.00 per share on Jul 05 ’24. After the transaction, the President and CEO now owns 886,654 company shares. In a previous transaction on Jul 01 ’24, Campbell Bradley L sold 1,400 shares at 10.00 per share. FOLD shares that President and CEO owns now total 886,654.

Among the insiders who sold shares, Campbell Bradley L disposed of 7,500 shares on Jun 03 ’24 at a per-share price of $10.00. This resulted in the President and CEO holding 886,654 shares of FOLD after the transaction. In another insider transaction, Campbell Bradley L sold 7,500 shares at $10.07 per share on May 01 ’24. Company shares held by the President and CEO now total 886,654.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, FOLD has a high of $14.57 and a low of $9.02.

As of this writing, FOLD has an earnings estimate of -$0.05 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of $0.02 per share and a lower estimate of -$0.1. The company reported an EPS of -$0.15 in the last quarter

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. FOLD’s latest balance sheet shows that the firm has $482.50M in Cash & Short Term Investments as of fiscal 2021. There were $440.13M in debt and $145.97M in liabilities at the time. Its Book Value Per Share was $0.44, while its Total Shareholder’s Equity was $307.37M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for FOLD is Buy with a score of 4.67.

Most Popular

Related Posts